Our Team

Investigators

Affiliated Faculty & Collaborators

Joshua Angrist, PhD

Joshua Angrist is a visiting scientist spending his sabbatical at the Smith Center for Outcomes Research from September 2025 – June 2025. He is the Ford Professor of Economics at MIT, a co-founder and director of MIT's Blueprint Labs, and a Research Associate at the National Bureau of Economic Research. Angrist and his collaborators develop and study innovative ways to harness the power of natural experiments to answer important economic questions. Angrist received the Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel in 2021 (with Co-Laureates Guido Imbens and David Card). He is a Fellow of the American Academy of Arts and Sciences and the Econometric Society, and has served on many editorial boards and as a co-editor of the Journal of Labor Economics. In addition to scholarship and teaching, Angrist and Steve Pischke co-authored Mostly Harmless Econometrics: An Empiricist's Companion and Mastering 'Metrics: The Path from Cause to Effect. In 2020, Angrist and frequent collaborator Parag Pathak founded Avela, an ed-tech startup that aims to enhance equity and access in schools of all kinds.

See Professor Angrist's research profile here.

Brett Carroll, MD

Brett Carroll, MD is the Director of the Section of Vascular Medicine and an Assistant Professor of Medicine at Harvard Medical School. He directs the BIDMC pulmonary embolism response team, is the medical director of the BIDMC Aortic Center, and director of lymphatic medicine. His research interests include venous thromboembolism, aortic disease, and lymphedema. He utilizes large administrative datasets to evaluate vascular diseases.

View Research Profile

Darae Ko, MD, MSc

Darae Ko, MD, MSc is Assistant Scientist II at Marcus Institute for Aging Research/Hebrew SeniorLife, BIDMC, Member of Faculty at Harvard Medical School, and practices as a general cardiologist at Boston Medical Center. Dr. Ko is dedicated to generating evidence for and implementation of safe and effective novel cardiovascular therapies in medically complex older adults. She is an expert in geriatric pharmacoepidemiology and leads Medicare Data- Atrial Fibrillation Outcomes Research Program at Marcus Institute.

View Research Profile

Dhaval Kolte, MD, PhD

Dhaval Kolte, MD, PhD is a Structural Interventional Cardiologist at Massachusetts General Hospital and an Assistant Professor of Medicine at Harvard Medical School. Dr. Kolte’s research focuses on understanding the reasons underlying hospital-level variation in outcomes of transcatheter heart valve interventions and identifying modifiable practices and processes of care associated with improved outcomes. He is also interested in comparative effectiveness of transcatheter heart valve therapies. His clinical area of expertise is in interventional cardiology, with an emphasis in structural heart disease and transcatheter aortic, mitral, and tricuspid valve interventions.
View Research Profile

Anica Law, MD, MSc

Anica Law, MD, MSc is an Assistant Professor of Medicine at Boston University. She is a pulmonary-critical care physician and a health services researcher with a focus on improving outcomes of critically ill patients. Her research leverages large clinical and administrative databases to characterize the effects of external (e.g. legislation), internal (e.g. hospital and provider), and patient drivers on practice patterns, as well as to determine how practice pattern variations affect long-term outcomes of the critically ill.

View Research Profile

Stephen Mein, MD

Stephen Mein, MD is a pulmonary and critical care physician at Beth Israel Deaconess Medical Center (BIDMC) and an Instructor in Medicine at Harvard Medical School. He completed medical school at the University of Virginia, Internal Medicine residency at BIDMC, fellowship at the Harvard Combined Pulmonary and Critical Care Fellowship, and postdoctoral research training at the Smith Center for Outcomes Research. Dr. Mein’s research leverages large survey and administrative data and causal inference methods to understand the intersections of health policy, care delivery, and clinical outcomes for patients with pulmonary conditions, with a particular focus on asthma and chronic obstructive pulmonary disease (COPD).